National Heart, Lung, And Blood Institute (nhlbi)
Clinical trials sponsored by National Heart, Lung, And Blood Institute (nhlbi), explained in plain language.
-
New drug could help lung transplant patients fight off rejection
Disease control Not yet recruitingThis early-stage study tests a drug called fostamatinib in 30 adults who have had a lung transplant and developed donor-specific antibodies (DSA), which can lead to organ rejection. Participants take the drug or a placebo daily for 8 weeks while continuing standard care. The main…
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Turmeric gel could ease sickle cell symptoms – early trial begins
Symptom relief Not yet recruitingThis early study tests a skin gel made from curcumin (found in turmeric) in 25 adults with stable sickle cell disease. The gel is applied to the forearms twice a week for 6 weeks to see if it is safe and well-tolerated. Researchers will also check how much curcumin gets into the …
Phase: PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Symptom relief
Last updated May 26, 2026 02:48 UTC
-
Super-Computer sharpens heart scans without extra radiation
Knowledge-focused Not yet recruitingThis study aims to improve heart CT images using advanced computer techniques. Researchers will take standard CT scans from 1,000 adults with heart disease and use a super-computer to create higher-resolution versions. The goal is to see if these enhanced images show more detail …
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated May 26, 2026 03:06 UTC